Search Results - "Carpagnano, F"

HPV in exhaled breath condensate of lung cancer patients by Carpagnano, G E, Koutelou, A, Natalicchio, M I, Martinelli, D, Ruggieri, C, Di Taranto, A, Antonetti, R, Carpagnano, F, Foschino-Barbaro, M P

“…Background: A recent intriguing carcinogenetic hypothesis for lung cancer foresees its viral aetiology. The human papilloma virus (HPV) is the main virus…”
Get full text

Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection by Bavaro, DF, Diella, L, Solimando, AG, Cicco, S, Buonamico, E, Stasi, C, Ciannarella, M, Marrone, M, Carpagnano, F, Resta, O, Carpagnano, GE, Palmieri, VO, Vacca, A, Dell'Aera, M, Dell'Erba, A, Migliore, G, Aricò, M, Saracino, A

“…The early administration of anti-SARS-CoV-2 monoclonal antibodies (mAb) could decrease the risk of severe disease and the need of inpatients care. Herein, our…”
Get full text

Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis by Matteo, M., Cicinelli, E., Neri, M., Carrubba, R., Carpagnano, F.A., Romeo, F., Scutiero, G., Greco, P., Garlanda, C., Vendemiale, G., Levi Setti, P.E., Serviddio, G.

“…The study aimed to explore the type 1 and type 2 cytokines expression in the endometrium from women affected by endometriosis compared to controls. The…”
Get full text

Prostate Multiparametric MRI: Evaluation of Recurrence and Post-treatment Changes by Carpagnano, F. A., Eusebi, L., Giannubilo, W., Fenu, F., Safi, M., Bartelli, F., Guglielmi, G.

“…Purpose of Review This article reviews all the most common therapeutic strategies of prostate cancer, systemic or local, and all the following…”
Get full text

Multiparametric MRI: Local Staging of Prostate Cancer by Carpagnano, F. A., Eusebi, L., Tupputi, U., Testini, V., Giannubilo, W., Bartelli, F., Guglielmi, G.

“…Purpose of Review To highlight the recent evidence about the use of mp-MRI in the local staging of prostate cancer, enhancing the potential benefits compared…”
Get full text

Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer by Carpagnano, G E, Foschino-Barbaro, M P, Resta, O, Gramiccioni, E, Carpagnano, F

“…One recent line of cancer research is currently directed to the study of growth factors. Of increasing interest is endothelin-1 (ET-1), a mitogenic factor…”
Get more information

SARS-CoV-2 indoor contamination: considerations on anti-COVID-19 management of ventilation systems, and finishing materials in healthcare facilities by Gola, M, Caggiano, G, De Giglio, O, Napoli, C, Diella, G, Carlucci, M, Carpagnano, L F, D'Alessandro, D, Joppolo, C M, Capolongo, S, Montagna, M T

“…Many of the devastating pandemics and outbreaks of last centuries have been caused by enveloped viruses. The recent pandemic of Coronavirus disease 2019…”
Get more information

Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer by CARPAGNANO, G. E, RESTA, O, FOSCHINO-BARBARO, M. P, GRAMICCIONI, E, CARPAGNANO, F

“…Despite recent advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC), most patients still present with advanced stage disease at the…”
Get full text

PP85 Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients by Tommasi, S, Carpagnano, G.E, Pinto, R, Foschino-Barbaro, M.P, Spanevello, A, Carpagnano, F, Mulè, G, Paradiso, A

Get full text

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer by Lorusso, V., Crucitta, E., Panza, N., Silvestris, N., Guida, M., Carpagnano, F., Mancarella, S., Sambiasi, D., De Lena, M.

“…Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel combined with a fixed dose of gemcitabine and vinorelbine in the…”
Get full text

Prostate Multiparametric MRI: Common Pitfalls in Primary Diagnosis and How to Avoid Them by Eusebi, L., Carpagnano, F. A., Sortino, G., Bartelli, F., Guglielmi, G.

“…Purpose of Review To provide the radiologist with basic knowledge about normal and abnormal findings in the prostatic mp-MRI, taking a look at the possible…”
Get full text

Prostate Cancer Ultrasound: Is Still a Valid Tool? by Carpagnano, F. A., Eusebi, L., Carriero, S., Giannubilo, W., Bartelli, F., Guglielmi, G.

“…Purpose of Review The main purpose of this paper review is to highlight the latest ultrasound (US) imaging technologies of the prostate gland, an organ…”
Get full text

Can beaches and bathing environments represent a risk of spreading COVID-19? by Montagna, M T, Diella, G, De Giglio, O, Triggiano, F, Carlucci, M, Carpagnano, F L, Caggiano, G

Get more information

3p Microsatellite Alterations in Exhaled Breath Condensate from Patients with Non-Small Cell Lung Cancer by Carpagnano, Giovanna E, Foschino-Barbaro, Maria Pia, Mule, Giuseppina, Resta, Onofrio, Tommasi, Stefania, Mangia, Anita, Carpagnano, Francesco, Stea, Gaetano, Susca, Antonia, Di Gioia, Giuseppe, De Lena, Mario, Paradiso, Angelo

“…The still-high mortality for lung cancer urgently requires the availability of new, noninvasive diagnostic tools for use in early diagnosis and screening…”
Get full text

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association by Douillard, J.-Y., Rosell, R., Delena, M., Legroumellec, A., Torres, A., Carpagnano, F.

“…Abstract only…”
Get full text

Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung Cancer by LORUSSO, V, CARPAGNANO, F, PALAZZO, S, DE LENA, M, FRASCI, G, PANZA, N, DI RIENZO, G, CISTERNINO, M. L, NAPOLI, G, ORLANDO, S, CINIERI, S, BRUNETTI, C

“…To determine the maximum-tolerated dose of gemcitabine when combined with a fixed dose of vinorelbine in the treatment of non-small-cell lung cancer (NSCLC)…”
Get full text

Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group by COMELLA, P, FRASCI, G, NICOLELLA, G, NATALE, M, CARPAGNANO, F, PACILIO, C, DE LENA, M, BIANCO, A, COMELLA, G, PANZA, N, MANZIONE, L, LORUSSO, V, DI RIENZO, G, CIOFFI, R, DE CATALDIS, G, MAIORINO, L, BILANCIA, D

“…In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and very active in patients with…”
Get full text

The triplet vinorelbine (NVB), ifosfamide (IFO) and cisplatin (CDDP) (NIP) used as post-operative treatment versus surgery alone in patients having received primary chemotherapy (CT) for locally advanced (LA) non small cell lung cancer (NSCLC) by Grunenwald, D., Ziolo, G., Olechnowicz, H., Dahabreh, J., Carpagnano, F., Leong, S., Fittipaldo, A., De Almeida, C., Aubert, D., Gottfried, M.

“…Abstract only…”
Get full text

The triplet vinorelbine (NVB), ifosfamide (IFO) and cisplatin (CDDP) (NIP) used as post-operative treatment versus surgery alone in patients having received primary chemotherapy (CT) for locally advanced (LA) non small cell lung cancer (NSCLC) by Grunenwald, D., Ziolo, G., Olechnowicz, H., Dahabreh, J., Carpagnano, F., Leong, S., Fittipaldo, A., De Almeida, C., Aubert, D., Gottfried, M.

“…Abstract only…”
Get full text

Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts) by Rosell, R., de Lena, M., Carpagnano, F., Ramlau, R., Gonzalez-Larriba, J., Grodzki, T., Le Groumellec, A., Aubert, D., Gasmi, J., Douillard, J.

Get full text